HER2-Specific CAR T-Cell Therapy Active in Progressive Glioblastoma – Cancer Network
|
HER2-Specific CAR T-Cell Therapy Active in Progressive Glioblastoma
Cancer Network Administration of autologous HER2-specific chimeric antigen receptor (CAR)-modified virus specific T Cells (VSTs) was safe and had clinical benefit for some patients with progressive glioblastoma, a disease with limited effective therapeutic options. |
